ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
Adicet Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$4.53−0.04 (-0.88%)
Close on Oct 19, 2026
- Market cap
- $48.68M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$11.31 (−71.40%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $48.68M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.41
- Dividend yield
- –
- Free cash flow yield
- -174.55%
Fundamentals
- Net income
- -$98.97M
- EPS, diluted
- -$11.43
- Free cash flow
- -$84.97M
- Book value per share
- $11.18
- Diluted shares
- 11M
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Operating income
-$103.71M
Net income
-$98.97M
EPS, diluted
-$11.43
Free cash flow
-$84.97M
Reported periodTrailing twelve months